SMARCA4-(BRG1) immunohistochemistry is particularly critical, revealing a loss of nuclear BRG1 staining in tumor cells while adjacent non-neoplastic stromal cells retain staining (serving as internal controls) (8). This evidence concerns the gene SMARCA4 and neoplasm.